Blackwell receives Duke Distinguished Alumni Award
The Duke Alumni Association has recognized Kimberly Blackwell, MD, professor of medicine (Medical Oncology), with a Distinguished Alumni Award.
Kamal is fellow of American Academy of Hospice and Palliative Medicine
Arif Kamal, MD, assistant professor of medicine (Medical Oncology), recently earned the designation Fellow of the American Academy of Hospice and Palliative Medicine.
9/25/15: Grand Rounds, Research Seminar returns and two celebrations
Friday will be a particularly busy day in the Department of Medicine. The Department will host two conferences and two of its centers will mark anniversaries with seminars and celebrations.
Can a Modified Poliovirus Fight Advanced Prostate Cancer Too?
Duke researchers made a big splash in the news last spring when 60 Minutes featured the success of early clinical trials using a modified poliovirus in the fight against a deadly form of brain cancer.
Q & A with Steve Patierno: “A moral imperative”
Steven Patierno, PhD, professor of medicine (Medical Oncology) and deputy director of the Duke Cancer Institute, studies the biological underpinnings of disparities in prostate cancer among African American and Caucasian men.
Study finds thin colorectal cancer patients have shorter survival than obese patients
[video:https://www.youtube.com/watch?t=15&v=X-cbhrlGcC8]
Although being overweight with a high body-mass index (BMI) has long been associated with a higher risk for colorectal cancer, thinner patients might not fare as well after treatment for advanced cancer, according to a new study from Duke Medicine.
News report: Patierno discusses racial disparities in prostate cancer
Steven Patierno, PhD, professor of medicine (Medical Oncology) and deputy director of the Duke Cancer Institute, talked with the News & Observer about his research on genetic aspect of the disparity in prostate cancer and controversial screening guidelines.
Philanthropies announce new program to support early-career scientists
Three of the nation’s largest philanthropies – the Howard Hughes Medical Institute, the Bill & Melinda Gates Foundation, and the Simons Foundation – have announced a new partnership to provide much needed research support to outstanding early-career scientists in the United States.
Through the new Faculty Scholars Program, the philanthropies will invest a total of $148 million in research support over the program’s first five years.